April 28, 2020 / 8:17 AM / a month ago

BRIEF-Pharma Mar Starts Aplicov-PC Clinical Trial With Aplidin For Treatment Of Covid-19

April 28 (Reuters) - Pharma Mar SA:

* SAYS STARTS APLICOV-PC CLINICAL TRIAL WITH APLIDIN® (PLITIDEPSIN) FOR THE TREATMENT OF PATIENTS WITH COVID-19, AFTER AUTHORIZATION FROM THE SPANISH AGENCY OF MEDICINES AND HEALTH PRODUCTS' (AEMPS) Source text: bit.ly/3aMZq0W Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below